Rhumbline Advisers Immutep LTD Transaction History
Rhumbline Advisers
- $105 Billion
- Q2 2024
A detailed history of Rhumbline Advisers transactions in Immutep LTD stock. As of the latest transaction made, Rhumbline Advisers holds 26,156 shares of IMMP stock, worth $57,804. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,156
Previous 26,943
2.92%
Holding current value
$57,804
Previous $62,000
16.13%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding IMMP
# of Institutions
36Shares Held
2.38MCall Options Held
526KPut Options Held
222K-
Black Rock Inc. New York, NY839KShares$1.85 Million0.0% of portfolio
-
Meridian Wealth Management, LLC381KShares$842,4520.09% of portfolio
-
Susquehanna International Group, LLP Bala Cynwyd, PA248KShares$548,3380.0% of portfolio
-
Jane Street Group, LLC New York, NY126KShares$277,5360.0% of portfolio
-
Old Mission Capital LLC113KShares$249,8110.01% of portfolio
About IMMUTEP Ltd
- Ticker IMMP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,624,000
- Market Cap $191M
- Description
- Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as...